ArticleCancers2020

Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma.

Yeonhwa Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.